Clinical Development ManagerViiV Healthcare
Disclosure: GlaxoSmithKline (Individual(s) Involved: Self): Shareholder; ViiV Healthcare (Individual(s) Involved: Self): Employee
Oral Abstract
Saturday, October 24, 202011:00am – 11:10am EDT